Celldex Therapeutics | CLDX - Frais De Vente Et D'Administration

Prix De L'Action
33.89
Variation Quotidienne
0.03 0.09%
Mensuellement
8.10%
Annuel
79.22%
Q2 Prévisions
31.64




Frais De Vente Et D'Administration Changement Date
AbbVie USD 3.58B 316M 2026-03
Agenus USD 10.56M 13.04M 2025-12
Amgen USD 1.58B 354M 2026-03
Bristol-Myers Squibb USD 1.62B 564M 2026-03
Celldex Therapeutics USD 7.84M 1.21M 2025-12
Glaxosmithkline GBP 3.56B 650.29M 2025-12
Nektar Therapeutics USD 10.17M 10.17M 2025-12
Northwest Biotherapeutics USD 7.07M 1.06M 2025-09
Pfizer USD 2.92B 1.16B 2026-03
Rigel Pharmaceuticals USD 27.04M 1M 2024-09
Roche Holding CHF 7.28B 3.99B 2025-12